Loading...
Conserved anchorless surface proteins as group A streptococcal vaccine candidates.
Henningham, Anna Chiarot, Emiliano Gillen, Christine M Cole, Jason N Rohde, Manfred Fulde, Marcus Ramachandran, Vidiya Cork, Amanda J Hartas, Jon Magor, Graham
Henningham, Anna
Chiarot, Emiliano
Gillen, Christine M
Cole, Jason N
Rohde, Manfred
Fulde, Marcus
Ramachandran, Vidiya
Cork, Amanda J
Hartas, Jon
Magor, Graham
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2012-10
Submitted date
Files
Loading...
original manuscript
Adobe PDF, 1.85 MB
Other Titles
Abstract
Streptococcus pyogenes (group A Streptococcus (GAS)) causes ∼700 million human infections each year, resulting in over 500,000 deaths. The development of a commercial GAS vaccine is hampered by the occurrence of many unique GAS serotypes, antigenic variation within the same serotype, differences in serotype geographical distribution, and the production of antibodies cross-reactive with human tissue that may lead to autoimmune disease. Several independent studies have documented a number of GAS cell wall-associated or secreted metabolic enzymes that contain neither N-terminal leader sequences nor C-terminal cell wall anchors. Here, we applied a proteomic analysis of serotype M1T1 GAS cell wall extracts for the purpose of vaccine development. This approach catalogued several anchorless proteins and identified two protective vaccine candidates, arginine deiminase and trigger factor. These surface-exposed enzymes are expressed across multiple GAS serotypes exhibiting ≥99% amino acid sequence identity. Vaccine safety concerns are alleviated by the observation that these vaccine candidates lack human homologs, while sera from human populations suffering repeated GAS infections and high levels of autoimmune complications do not recognize these enzymes. Our study demonstrates anchorless cell surface antigens as promising vaccine candidates for the prevention of GAS disease.
Citation
Conserved anchorless surface proteins as group A streptococcal vaccine candidates. 2012, 90 (10):1197-207 J. Mol. Med.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1432-1440
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Archived with thanks to Journal of molecular medicine (Berlin, Germany)